This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

The US Food and Drug Administration (FDA) recently announced a strategic roadmap to phase out animal testing requirements for ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.

Severe cases in women are rare. Marstacimab is a human monoclonal antibody that targets tissue factor pathway inhibitor. This inhibition enables an alternative blood clotting pathway that does not ...

Alphamab Oncology (stock code: 9966.HK) announced that the preclinical data on two novel bispecific antibody-drug conjugates (ADCs) JSKN021 and JSKN022 were presented as posters at the 2025 American ...

The FDA is shifting towards a more human-relevant approach to drug testing, encouraging the use of New Approach Methodologies such as laboratory-grown human cell models, organ-on-a-chip systems, ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced it will be phasing out the current requirements for animal testing in ...